A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital, highlighted several ...

RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

RBC has partnered with Cohere, a company specializing in security and privacy-focused enterprise AI, to co-develop North for ...

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

RBC Capital lowered the firm’s price target on Sun Communities (SUI) to $134 from $135 and keeps an Outperform rating on the ...

RBC Capital lowered the firm’s price target on Equity Lifestyle (ELS) to $69 from $72 and keeps a Sector Perform rating on ...

RBC Capital upgraded Lennar (LEN) to Sector Perform from Underperform with an unchanged price target of $130. The upgrade is valuation-based ...

Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.

A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Exelixis (EXEL – Research Report) on January 7 and set a price target of $38.00.